APRINOIA Therapeutics

Boston, United States

Biotechnology, Neuorscience

$4.4M raised

Sep 2023

Venture - Series Unknown

Biotechnology Health Diagnostics Medical Neuroscience Therapeutics

Top Investors

IMM InvestmentIMM Private EquityDCI PartnersAlzheimer's Drug Discovery FoundationCompany K Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about APRINOIA Therapeutics

How much funding has APRINOIA Therapeutics raised?

APRINOIA Therapeutics has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.

Who are APRINOIA Therapeutics's investors?

APRINOIA Therapeutics's investors include IMM Investment, IMM Private Equity, DCI Partners, Alzheimer's Drug Discovery Foundation, Company K Partners.

Where is APRINOIA Therapeutics headquartered?

APRINOIA Therapeutics is headquartered in Boston, United States.

What does APRINOIA Therapeutics do?

Biotechnology, Neuorscience

What stage is APRINOIA Therapeutics at?

APRINOIA Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 11, 2023.

MLA

"APRINOIA Therapeutics — Funding & Investors." VCBacked, September 11, 2023, https://www.vcbacked.co/company/aprinoia-therapeutics. Accessed June 9, 2026.

APA

VCBacked. (2023). APRINOIA Therapeutics — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/aprinoia-therapeutics

Wikipedia (cite web)

{{cite web |title=APRINOIA Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aprinoia-therapeutics |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 11, 2023.